The total return over the past 12 months is -9.27% vs. +16.94% for the S&P 500. So far it's up -27.38% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (9.27%) | (21.61%) | (32.14%) | N/A | N/A | N/A |
| Total Return CAGR | (9.27%) | (21.61%) | (32.14%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Unicycive Therapeutics, Inc. (UNCY)
| Year | Start price | End price | UNCY Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $5.77 | $4.19 | (27.38%) | +14.51% | (41.89%) |
| 2025 | $7.94 | $5.77 | (27.33%) | +17.72% | (45.05%) |
| 2024 | $8.68 | $7.94 | (8.53%) | +24.89% | (33.42%) |
| 2023 | $5.40 | $8.68 | +60.74% | +26.19% | +34.55% |
| 2022 | $20.60 | $5.40 | (73.79%) | (18.17%) | (55.62%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
